Back to RA CAPITAL MANAGEMENT, L.P. RA CAPITAL MANAGEMENT, L.P.

ELDNELDN
5 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.RA CAPITAL MANAGEMENT, L.P.'s holdings in ELEDON PHARMACEUTICALS INC

No. RA Capital Management exited its ELDN (Eledon Pharmaceuticals) position in Q4 2025. Its Q3 2025 13F listed 3,566,338 shares worth $9.2M. RA Capital Management first reported ELDN in Q4 2024 and held it in 4 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$14.7M

Total Shares Change

-3.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q4
Latest
Exited
0
-100.0%
$00.0%$1.51
0
2025-Q3
Unchanged
3.6M
0.0%
$9.2M0.1%$2.54
0
2025-Q2
Unchanged
3.6M
0.0%
$9.7M0.2%$2.69
0
2025-Q1
Unchanged
3.6M
0.0%
$12.1M0.2%$3.35
0
2024-Q4
New
3.6M
-
$14.7M0.2%$4.14
46

Other major holders of ELDN: BlackRock, Inc., FMR LLC, VANGUARD CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used